Medicaid Provider Spending

$1.09 trillion in Medicaid claims data, 2018–2024 · 617K+ providers

GODWIN MEDICAL PC

NPI: 1679749808 · BRONX, NY 10463 · Primary Care Clinic/Center · NPI assigned 05/07/2008

$316K
Total Medicaid Paid
152,788
Total Claims
137,349
Beneficiaries
140
Codes Billed
2018-01
First Month
2024-12
Last Month

Provider Details

Authorized OfficialPEREZ, LUISA (INTERNAL MEDICINE DOCTOR)
NPI Enumeration Date05/07/2008

Monthly Spending Trend

Yearly Breakdown

YearClaimsTotal Paid
2018 24,375 $72K
2019 25,965 $50K
2020 22,560 $39K
2021 25,160 $127K
2022 14,465 $15K
2023 19,308 $5K
2024 20,955 $8K

Billing Codes

CodeDescriptionClaimsBeneficiariesTotal Paid
99213 Office or other outpatient visit for the evaluation and management of an established patient, low complexity 6,134 5,418 $65K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe 1,564 1,390 $52K
99401 7,781 6,546 $38K
86328 1,068 1,020 $21K
99442 2,049 1,870 $19K
G0447 Face-to-face behavioral counseling for obesity, 15 minutes 2,478 2,246 $19K
86769 749 709 $13K
99212 Office or other outpatient visit for the evaluation and management of an established patient, straightforward 1,984 1,829 $12K
99396 Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years 981 981 $11K
G8510 Screening for depression is documented as negative, a follow-up plan is not required 7,060 5,723 $7K
99202 Office or other outpatient visit for the evaluation and management of a new patient, straightforward 720 719 $7K
99395 Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years 408 408 $6K
90460 Immunization administration through 18 years of age via any route, first or only component 376 370 $5K
99443 686 639 $5K
G0446 Annual, face-to-face intensive behavioral therapy for cardiovascular disease, individual, 15 minutes 174 149 $3K
H0001 Alcohol and/or drug assessment 3,069 3,033 $3K
99402 442 422 $3K
0012A 64 64 $2K
99394 Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) 74 74 $2K
0011A 58 58 $2K
0064A 54 54 $2K
G0108 Diabetes outpatient self-management training services, individual, per 30 minutes 183 163 $2K
36415 Collection of venous blood by venipuncture 5,410 5,241 $2K
93000 100 100 $2K
99215 Prolong outpt/office vis 24 22 $1K
3074F 1,251 1,203 $1K
85013 253 252 $1K
3078F 1,071 1,023 $1K
92551 406 405 $947.32
99393 Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) 39 39 $868.90
H0049 Alcohol and/or drug screening 256 238 $818.00
99407 30 24 $788.47
97802 1,058 985 $654.82
99385 25 25 $611.89
G0444 Annual depression screening, 5 to 15 minutes 50 50 $569.87
85018 246 245 $524.76
G0270 Medical nutrition therapy; reassessment and subsequent intervention(s) following second referral in same year for change in diagnosis, medical condition or treatment regimen (including additional hours needed for renal disease), individual, face to face with the patient, each 15 minutes 103 103 $522.61
1126F 3,353 2,850 $437.43
1159F 4,408 3,590 $390.00
81000 261 252 $329.18
99173 157 157 $300.00
99406 56 48 $273.75
1160F 2,685 2,601 $197.53
99214 Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity 274 271 $84.63
H0002 Behavioral health screening to determine eligibility for admission to treatment program 3,218 3,154 $44.07
87320 55 53 $40.15
90686 197 195 $38.08
80061 Lipid panel 14 14 $23.98
99211 Office or other outpatient visit for the evaluation and management of an established patient, minimal severity 17 17 $23.64
3077F 26 26 $22.50
90656 84 84 $19.77
3079F 115 110 $17.51
93010 Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only 12 12 $15.79
99000 3,989 3,789 $4.50
G8427 Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications 6,555 5,592 $0.64
G9507 Documentation that the patient is on a statin medication or has documentation of a valid contraindication or exception to statin medications; contraindications/exceptions that can be defined by diagnosis codes include pregnancy during the measurement period, active liver disease, rhabdomyolysis, end stage renal disease on dialysis and heart failure; provider documented contraindications/exceptions include breastfeeding during the measurement period, woman of child-bearing age not actively taking birth control, allergy to statin, drug interaction (hiv protease inhibitors, nefazodone, cyclosporine, gemfibrozil, and danazol) and intolerance (with supporting documentation of trying a statin at least once within the last 5 years or diagnosis codes for myostitis or toxic myopathy related to drugs) 210 181 $0.57
G9664 Patients who are currently statin therapy users or received an order (prescription) for statin therapy 209 180 $0.57
3008F 5,100 4,269 $0.36
91306 39 39 $0.04
G8752 Most recent systolic blood pressure < 140 mmhg 2,585 2,380 $0.03
G8754 Most recent diastolic blood pressure < 90 mmhg 2,677 2,458 $0.03
G8783 Normal blood pressure reading documented, follow-up not required 6,043 5,084 $0.02
3049F 38 37 $0.02
G8950 Elevated or hypertensive blood pressure reading documented, and the indicated follow-up is documented 1,869 1,579 $0.01
91301 128 127 $0.01
G0468 Federally qualified health center (fqhc) visit, ippe or awv; a fqhc visit that includes an initial preventive physical examination (ippe) or annual wellness visit (awv) and includes a typical bundle of medicare-covered services that would be furnished per diem to a patient receiving an ippe or awv 649 649 $0.00
97803 755 755 $0.00
3725F 4,764 3,952 $0.00
3050F 161 158 $0.00
G0435 Infectious agent antibody detection by rapid antibody test, hiv-1 and/or hiv-2, screening 38 38 $0.00
G8730 Pain assessment documented as positive using a standardized tool and a follow-up plan is documented 209 196 $0.00
3016F 2,393 2,349 $0.00
G8753 Most recent systolic blood pressure >= 140 mmhg 292 255 $0.00
G0438 Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit 79 79 $0.00
G9622 Patient not identified as an unhealthy alcohol user when screened for unhealthy alcohol use using a systematic screening method 2,541 2,516 $0.00
99001 627 610 $0.00
1033F 1,093 1,091 $0.00
0556F 751 713 $0.00
G8417 Bmi is documented above normal parameters and a follow-up plan is documented 2,039 1,685 $0.00
1026F 24 24 $0.00
G8731 Pain assessment using a standardized tool is documented as negative, no follow-up plan required 2,080 1,895 $0.00
G8935 Clinician prescribed angiotensin converting enzyme (ace) inhibitor or angiotensin receptor blocker (arb) therapy 168 133 $0.00
2025F 12 12 $0.00
S0316 Disease management program, follow-up/reassessment 33 33 $0.00
G8976 Most recent hemoglobin (hgb) level >= 10 g/dl 67 67 $0.00
G8431 Screening for depression is documented as being positive and a follow-up plan is documented 34 31 $0.00
0521F 63 62 $0.00
G8938 Bmi is documented as being outside of normal parameters, follow-up plan is not documented, documentation the patient is not eligible 231 193 $0.00
G8484 Influenza immunization was not administered, reason not given 244 203 $0.00
G8482 Influenza immunization administered or previously received 78 67 $0.00
G9150 National committee for quality assurance - level 3 medical home 124 122 $0.00
99204 Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity 53 53 $0.00
G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) 146 136 $0.00
G9820 Documentation of a chlamydia screening test with proper follow-up 76 71 $0.00
G0476 Infectious agent detection by nucleic acid (dna or rna); human papillomavirus (hpv), high-risk types (e.g., 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 68) for cervical cancer screening, must be performed in addition to pap test 12 12 $0.00
4004F 17 17 $0.00
1039F 26 24 $0.00
4013F 40 34 $0.00
1158F 16 16 $0.00
77062 12 12 $0.00
G0143 Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, with manual screening and rescreening by cytotechnologist under physician supervision 13 13 $0.00
G9276 Documentation that patient is a current tobacco user 30 25 $0.00
G8420 Bmi is documented within normal parameters and no follow-up plan is required 3,159 2,617 $0.00
4293F 2,201 2,177 $0.00
G9275 Documentation that patient is a current non-tobacco user 2,954 2,923 $0.00
4290F 1,430 1,418 $0.00
2001F 4,348 3,699 $0.00
1220F 3,709 3,165 $0.00
G9273 Blood pressure has a systolic value of < 140 and a diastolic value of < 90 2,103 1,989 $0.00
G9459 Currently a tobacco non-user 2,222 2,203 $0.00
G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit 695 695 $0.00
3011F 846 796 $0.00
1000F 2,438 2,357 $0.00
1036F 5,178 4,188 $0.00
2010F 2,404 2,360 $0.00
2000F 4,269 3,632 $0.00
G9228 Chlamydia, gonorrhea and syphilis screening results documented (report when results are present for all of the 3 screenings) 29 29 $0.00
0001F 510 468 $0.00
G8755 Most recent diastolic blood pressure >= 90 mmhg 261 230 $0.00
G9903 Patient screened for tobacco use and identified as a tobacco non-user 348 335 $0.00
G9274 Blood pressure has a systolic value of =140 and a diastolic value of = 90 or systolic value < 140 and diastolic value = 90 or systolic value = 140 and diastolic value < 90 144 134 $0.00
G9432 Asthma well-controlled based on the act, c-act, acq, or ataq score and results documented 123 113 $0.00
96127 44 44 $0.00
3017F 42 41 $0.00
2015F 54 48 $0.00
G8418 Bmi is documented below normal parameters and a follow-up plan is documented 46 38 $0.00
G9902 Patient screened for tobacco use and identified as a tobacco user 62 52 $0.00
A4556 Electrodes, (e.g., apnea monitor), per pair 38 38 $0.00
2016F 54 48 $0.00
2023F 12 12 $0.00
1005F 54 48 $0.00
G0123 Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, screening by cytotechnologist under physician supervision 14 14 $0.00
2033F 12 12 $0.00
3080F 56 54 $0.00
3048F 15 14 $0.00
3075F 17 14 $0.00
1123F 18 18 $0.00
3072F 12 12 $0.00
0513F 13 12 $0.00
G0103 Prostate cancer screening; prostate specific antigen test (psa) 12 12 $0.00